These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8257958

  • 1. Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands.
    Herings RM, Stricker BH, Leufkens HG, Bakker A, Sturmans F, Urquhart J.
    Pharm World Sci; 1993 Oct 15; 15(5):212-8. PubMed ID: 8257958
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardiac actions of antihistamines.
    Woosley RL.
    Annu Rev Pharmacol Toxicol; 1996 Oct 15; 36():233-52. PubMed ID: 8725389
    [Abstract] [Full Text] [Related]

  • 4. Is QT interval prolongation harmful? A regulatory perspective.
    Botstein P.
    Am J Cardiol; 1993 Aug 26; 72(6):50B-52B. PubMed ID: 8256756
    [Abstract] [Full Text] [Related]

  • 5. Additional causes of torsades de pointes.
    Kelloway JS, Pongowski MA, Schoenwetter WF.
    Mayo Clin Proc; 1995 Feb 26; 70(2):197. PubMed ID: 7845049
    [No Abstract] [Full Text] [Related]

  • 6. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM.
    Clin Ther; 1999 Feb 26; 21(2):281-95. PubMed ID: 10211532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA, Estes KS.
    Int J Clin Pharmacol Ther; 1998 May 26; 36(5):292-300. PubMed ID: 9629995
    [Abstract] [Full Text] [Related]

  • 9. Torsades de pointes ventricular tachycardia associated with overdose of astemizole.
    Rao KA, Adlakha A, Verma-Ansil B, Meloy TD, Stanton MS.
    Mayo Clin Proc; 1994 Jun 26; 69(6):589-93. PubMed ID: 8189766
    [Abstract] [Full Text] [Related]

  • 10. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR.
    JAMA; 1990 Dec 05; 264(21):2788-90. PubMed ID: 1977935
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
    Tsai WC, Tsai LM, Chen JH.
    J Formos Med Assoc; 1997 Feb 05; 96(2):144-6. PubMed ID: 9071844
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Possible interactions with terfenadine or astemizole.
    Zechnich AD, Hedges JR, Eiselt-Proteau D, Haxby D.
    West J Med; 1994 Apr 05; 160(4):321-5. PubMed ID: 8023479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia].
    Pohjola-Sintonen S.
    Duodecim; 1993 Apr 05; 109(2):164-6. PubMed ID: 8013320
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Torsades de pointes caused by the association of terfenadine and erythromycin].
    Gully C, Riem R.
    Ann Med Interne (Paris); 1994 Apr 05; 145(4):257-8. PubMed ID: 8092653
    [No Abstract] [Full Text] [Related]

  • 19. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.
    Pohjola-Sintonen S, Viitasalo M, Toivonen L, Neuvonen P.
    Eur J Clin Pharmacol; 1993 Apr 05; 45(2):191-3. PubMed ID: 8223844
    [Abstract] [Full Text] [Related]

  • 20. Torsade de pointes during the concomitant use of terfenadine and cimetidine.
    Ng PW, Chan WK, Chan TY.
    Aust N Z J Med; 1996 Feb 05; 26(1):120-1. PubMed ID: 8775544
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.